Adam Gerstenecker

Adam Gerstenecker
Assistant Professor

Assistant Professor (P), Neurology , School of Medicine
Scientist (C), Alzheimer's Disease Center , Neurology
Investigator (C), Evelyn F. McKnight Brain Institute , Neurology

Selected Publications

Academic Article

Year	Title	Altmetric
2018	Declining Financial Capacity in Mild Cognitive Impairment: A Six-Year Longitudinal Study. Archives of Clinical Neuropsychology. 34:152-161. 2018
2018	Exploring the Factor Structure of Financial Capacity in Cognitively Normal and Impaired Older Adults 2018
2017	Financial Capacity and its Cognitive Predictors in Progressive Multiple Sclerosis. Archives of Clinical Neuropsychology. 32:943-950. 2017
2017	Genetic influences on cognition in progressive supranuclear palsy. Movement Disorders. 32:1764-1771. 2017
2017	The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration. Archives of Clinical Neuropsychology. 32:861-875. 2017
2017	Medical decision-making capacity and its cognitive predictors in progressive MS: Preliminary evidence. Journal of the Neurological Sciences. 380:38-43. 2017
2017	Interventions for cognitive deficits in breast cancer survivors treated with chemotherapy. Cancer Nursing. 40:E11-E27. 2017
2017	Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive Impairment 2017
2017	White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer's Disease. 60:537-547. 2017
2016	Twelve-month recovery of medical decision-making capacity following traumatic brain injury. Neurology. 87:1052-1059. 2016
2016	Age and education corrected older adult normative data for a short form version of the financial capacity instrument. Psychological Assessment. 28:737-749. 2016
2016	Enhancing Medical Decision-Making Evaluations: Introduction of Normative Data for the Capacity to Consent to Treatment Instrument. Assessment. 23:232-239. 2016
2016	Introducing demographic corrections for the 10/36 Spatial Recall Test. International Journal of Geriatric Psychiatry. 31:410-415. 2016
2016	Both financial and cognitive decline predict clinical progression in MCI. Alzheimer Disease and Associated Disorders. 30:27-34. 2016
2015	Capacity of patients with brain metastases to make treatment decisions 2015
2015	Mild cognitive impairment: A history and the state of current diagnostic criteria. International Psychogeriatrics. 27:199-211. 2015
2015	Cognitive Predictors of Reasoning through Treatment Decisions in Patients with Newly Diagnosed Brain Metastases. Journal of the International Neuropsychological Society. 21:412-418. 2015
2015	Cognitive predictors of understanding treatment decisions in patients with newly diagnosed brain metastasis. Cancer. 121:2013-2019. 2015
2015	Impairment of medical decisional capacity in relation to Karnofsky Performance Status in adults with malignant brain tumor 2015
2014	Correcting for demographic variables on the modified telephone interview for cognitive status. American Journal of Geriatric Psychiatry. 22:1438-1443. 2014
2014	Cognition in patients with newly diagnosed brain metastasis: Profiles and implications. Journal of Neuro-Oncology. 120:179-185. 2014
2014	Tracking the Cognition of Nursing Home Residents 2014
2013	Behavioral abnormalities in progressive supranuclear palsy. Psychiatry Research. 210:1205-1210. 2013
2013	Measuring mild cognitive impairment in patients with Parkinson's disease. Movement Disorders. 28:626-633. 2013
2013	Functional impairment in progressive supranuclear palsy. Neurology. 80:380-384. 2013
2013	Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Archives of Clinical Neuropsychology. 28:104-113. 2013

Chapter

Year	Title	Altmetric
2012	Aging, Rehabilitation, and Psychology 2012
2010	Screening Instruments and Brief Batteries for Dementia. 503-530. 2010
2010	Neuropsychiatric and cognitive disorders in other Parkinsonian disorders. 261-274. 2010